Featured Image 3

Subchondral Solutions Receives FDA Clearance for Fenestrated Cannulated Screws

Subchondral Solutions received FDA 510(k) clearance to market the fenestrated, cannulated S4 Screw System™ to treat osteochondral fractures.
S4 is the company’s first FDA-cleared device in its platform that will address joint pain and damage with biomechanical and bioactive implants. The approach focuses on early biomechanical support for the entire bone/cartilage unit. Subchondral Solutions was established in California in 2014.

Source: Subchondral Solutions, Inc.

Read the full article at Orthoworld.com